<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://mpkb.org/lib/exe/css.php?s=feed" type="text/css"?>
<rss version="2.0">
    <channel xmlns:g="http://base.google.com/ns/1.0">
        <title>Marshall Protocol Knowledge Base - home:starting</title>
        <description></description>
        <link>https://mpkb.org/</link>
        <lastBuildDate>Sat, 25 Apr 2026 19:21:43 +0000</lastBuildDate>
        <generator>FeedCreator 1.8</generator>
        <image>
            <url>https://mpkb.org/_media/wiki/dokuwiki.svg</url>
            <title>Marshall Protocol Knowledge Base</title>
            <link>https://mpkb.org/</link>
        </image>
        <item>
            <title>Working with your physician</title>
            <link>https://mpkb.org/home/starting/physician?rev=1663188827&amp;do=diff</link>
            <description>&lt;table&gt;&lt;tr&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;04.21.2014&lt;/th&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;current&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 1:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 1:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;====== Working with your physician&amp;#160; &amp;#160; ======&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;====== Working with your physician&amp;#160; &amp;#160; ======&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;lt;relatedarticles&amp;gt; [[home:starting:usingforum:home_help_using_forums:a_a_href|5 key elements of MP]] &amp;lt;/article&amp;gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Patients on the Marshall Protocol (MP) must work with a licensed physician or other healthcare practitioner, such as a nurse practitioner or physician&amp;#039;s assistant. Patients who have the most successful outcomes are proactive and prepared. They internalize the requirements for the MP and, when necessary, work to address any of their physicians&amp;#039; concerns about the treatment. At this point, no doctors are certified in the use of the MP.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Patients on the Marshall Protocol (MP) must work with a licensed physician or other healthcare practitioner, such as a nurse practitioner or physician&amp;#039;s assistant. Patients who have the most successful outcomes are proactive and prepared. They internalize the requirements for the MP and, when necessary, work to address any of their physicians&amp;#039; concerns about the treatment. At this point, no doctors are certified in the use of the MP.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 115:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 118:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;{{tag&amp;gt;Starting_the_Marshall_Protocol}}&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;{{tag&amp;gt;Starting_the_Marshall_Protocol}}&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;lt;nodisp&amp;gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 121:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 125:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Legacy content&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Legacy content&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum32/10851.html#p131146 f121?purge=yes &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum32/10851.html#p131146 f121?purge=yes &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/view_topic.php?id=238&amp;amp;forum_id=2&amp;amp;jump_to=32135#p32135 e140 &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/view_topic.php?id=238&amp;amp;forum_id=2&amp;amp;jump_to=32135#p32135 e140 &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;&amp;lt;/nodisp&amp;gt; &lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
            <author>anonymous@undisclosed.example.com (Anonymous)</author>
            <pubDate>Wed, 14 Sep 2022 20:53:47 +0000</pubDate>
        </item>
        <item>
            <title>Checklist for starting the Marshall Protocol</title>
            <link>https://mpkb.org/home/starting/prempchecklist?rev=1663188827&amp;do=diff</link>
            <description>&lt;table&gt;&lt;tr&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;10.19.2018&lt;/th&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;current&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 3:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 3:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;====== Checklist for starting the Marshall Protocol&amp;#160; &amp;#160; &amp;#160;======&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;====== Checklist for starting the Marshall Protocol&amp;#160; &amp;#160; &amp;#160;======&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;lt;relatedarticles&amp;gt; [[home:starting:usingforum:home_help_using_forums:a_a_href|5 key elements of MP]] &amp;lt;/article&amp;gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Before [[home:starting|starting]] the Marshall Protocol (MP), patients should:&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Before [[home:starting|starting]] the Marshall Protocol (MP), patients should:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 65:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 68:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;{{tag&amp;gt;Starting_the_Marshall_Protocol}}&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;{{tag&amp;gt;Starting_the_Marshall_Protocol}}&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;lt;nodisp&amp;gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Legacy content&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Legacy content&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/view_topic.php?id=2275&amp;amp;forum_id=2&amp;amp;jump_to=51614#p51614 e2  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/view_topic.php?id=2275&amp;amp;forum_id=2&amp;amp;jump_to=51614#p51614 e2  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum2/10748.html e19  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum2/10748.html e19  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum2/366.html#p1870 e20  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum2/366.html#p1870 e20  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum32/7327.html f235  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum32/7327.html f235  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum32/2441.html f324&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum32/2441.html f324&lt;strong class=&quot;diff-mark&quot;&gt;&amp;lt;/nodisp&amp;gt; &lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
            <author>anonymous@undisclosed.example.com (Anonymous)</author>
            <pubDate>Wed, 14 Sep 2022 20:53:47 +0000</pubDate>
        </item>
        <item>
            <title>Safety warnings for the Marshall Protocol</title>
            <link>https://mpkb.org/home/starting/safety_warnings?rev=1663188827&amp;do=diff</link>
            <description>&lt;table&gt;&lt;tr&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;10.19.2018&lt;/th&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;current&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 84:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 84:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;{{tag&amp;gt;Resources_for_Physicians Starting_the_Marshall_Protocol}}&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;{{tag&amp;gt;Resources_for_Physicians Starting_the_Marshall_Protocol}}&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;lt;nodisp&amp;gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Updated wording, but still think it could be made even better with more work. --Joyful May&amp;#039;13&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Updated wording, but still think it could be made even better with more work. --Joyful May&amp;#039;13&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; * added &amp;quot;Xarelto increases the risk of bleeding and can cause serious or fatal bleeding. A specific antidote for rivaroxaban is not available. Because of high plasma protein binding, rivaroxaban is not expected to be dialyzable.&amp;quot; --Sallie Q May15&amp;#160;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; * altered 3rd line to &amp;#039;sufficient olmesartan medoxomil (Benicar) to ensure that patient does not run out if there is a delay in delivery or in renewing prescription&amp;#039; --- //Sallie Q 11.02.2016//&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt;alteration ( @ Patients must understand..) why the use of&amp;#160; telmisartan or azithromycin is considered particularly dangerous&amp;#160; --- //Sallie Q 09.15.2017/&lt;/strong&gt;/&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt; &lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt;&amp;lt;&lt;/strong&gt;/&lt;strong class=&quot;diff-mark&quot;&gt;nodisp&amp;gt; &lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
            <author>anonymous@undisclosed.example.com (Anonymous)</author>
            <pubDate>Wed, 14 Sep 2022 20:53:47 +0000</pubDate>
        </item>
        <item>
            <title>Therapeutic probe</title>
            <link>https://mpkb.org/home/starting/therapeutic_probe?rev=1663188827&amp;do=diff</link>
            <description>&lt;table&gt;&lt;tr&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;08.06.2017&lt;/th&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;current&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 7:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 7:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;In the context of the therapeutic probe, there are at least three responses or types of responses which indicate that continued treatment with the MP is warranted:&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;In the context of the therapeutic probe, there are at least three responses or types of responses which indicate that continued treatment with the MP is warranted:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * **photosensitivity** – Even if patients have never been light sensitive before, they may find lights to be too bright for comfort.&amp;#160; Patients are cautioned that photosensitivity (and other symptoms) can occur in response to a [[home:lifestyle:light:photosensitivity#withdrawal|withdrawal]] of typical levels of light exposure, even before the use of olmesartan is commenced.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * **photosensitivity** – Even if patients have never been light sensitive before, they may find lights to be too bright for comfort.&amp;#160; Patients are cautioned that photosensitivity (and other symptoms) can occur in response to a [[home:lifestyle:light:photosensitivity#withdrawal|withdrawal]] of typical levels of light exposure, even before the use of olmesartan is commenced.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; * **noticeable spike in symptoms** – Replacing &amp;#039;vitamin&amp;#039; D in the VDR, Benicar ensures reactivation of the innate immune response, allowing destruction of pathogenic bacteria. The effect of a strengthened immune system response is called immunopathology. Immunopathology feels bad because the killing of bacteria generates cytokines, endotoxins, and nitric oxide.&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; * **noticeable spike in symptoms** – Replacing &amp;#039;vitamin&amp;#039; D in the VDR, Benicar ensures reactivation of the innate immune response, allowing destruction of pathogenic bacteria&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;and viruses&lt;/strong&gt;. The effect of a strengthened immune system response is called immunopathology. Immunopathology feels bad because the killing of bacteria generates cytokines, endotoxins, and nitric oxide.&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * **noticeable relief in symptoms** – As an ARB, Benicar has profound anti-inflammatory effects, which manifest in a reduction in pain, fatigue, and other symptoms of Th1 disease.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * **noticeable relief in symptoms** – As an ARB, Benicar has profound anti-inflammatory effects, which manifest in a reduction in pain, fatigue, and other symptoms of Th1 disease.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 80:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 80:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;{{tag&amp;gt;Starting_the_Marshall_Protocol}}&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;{{tag&amp;gt;Starting_the_Marshall_Protocol}}&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;lt;nodisp&amp;gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 86:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 87:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;quot; Replacing &amp;#039;vitamin&amp;#039; D in the VDR, Benicar ensures reactivation of the innate immune response, allowing destruction of pathogenic bacteria.&amp;quot;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;quot; Replacing &amp;#039;vitamin&amp;#039; D in the VDR, Benicar ensures reactivation of the innate immune response, allowing destruction of pathogenic bacteria.&amp;quot;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Legacy content&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Legacy content&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum32/1419.html f341  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum32/1419.html f341  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum2/238.html#p23729 e136&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum2/238.html#p23729 e136&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;* **Instructions**: wd surely need to be closer to Phase 1 guidelines, esp. that Benicar shd come //before// mino, shd be taken alone for a wk or more, &amp;amp; that each dose of mino shd be taken for at least a week. However, this makes the probe longer than 2 wks. Does a probe need to get up to 100mg mino?&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;* **Instructions**: wd surely need to be closer to Phase 1 guidelines, esp. that Benicar shd come //before// mino, shd be taken alone for a wk or more, &amp;amp; that each dose of mino shd be taken for at least a week. However, this makes the probe longer than 2 wks. Does a probe need to get up to 100mg mino?&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 95:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 96:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Legacy content&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160; * Legacy content&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/view_topic.php?id=1080&amp;amp;forum_id=32&amp;amp;jump_to=46837#p46837 f2  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/view_topic.php?id=1080&amp;amp;forum_id=32&amp;amp;jump_to=46837#p46837 f2  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum32/4703.html#p42913 f277  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum32/4703.html#p42913 f277  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum37/3077.html s349  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum37/3077.html s349  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum32/2177.html f325  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum32/2177.html f325  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum32/1734.html f336  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum32/1734.html f336  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/forum32/3948.html f308  &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/forum32/3948.html f308  &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.marshallprotocol.com/view_topic.php?id=4304&amp;amp;forum_id=37&amp;amp;jump_to=88430#p88430 s81&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160; &amp;#160; *&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.marshallprotocol.com/view_topic.php?id=4304&amp;amp;forum_id=37&amp;amp;jump_to=88430#p88430 s81&lt;strong class=&quot;diff-mark&quot;&gt;&amp;lt;/nodisp&amp;gt; &lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
            <author>anonymous@undisclosed.example.com (Anonymous)</author>
            <pubDate>Wed, 14 Sep 2022 20:53:47 +0000</pubDate>
        </item>
    </channel>
</rss>
